Biocon has been a champion for meaningful transformation for over 4 decades and with Biocon Biologics, we have stood out as pioneers in developing & manufacturing biosimilars with affordable access to billions of patients.
From being credited with several ‘global firsts’ to global scale bio-manufacturing capabilities for insulins and monoclonal antibodies to world-class scientific talent pool with cutting-edge R&D experience to many more; at Biocon Biologics, we have been Transforming Healthcare. Transforming Lives.
